Sector Gamma AS
- SEC CIK
- 0001475373
- Latest filing
- Aug 12, 2026
Holdings in Q1 2025
Holdings as of Mar 31, 2025, filed May 13, 2025. Long positions only; changes compare share counts with Q4 2024.
- Positions
- 33
- +3 vs. Q4 2024
- Portfolio value
- $312.2M
- +$21.3M (+7.3%) vs. Q4 2024
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| BMYBristol Myers Squibb Co | Stock | 435,000 | $26.5M | 8.5% | +68,834+18.8% | Added | History |
| PFEPfizer Inc | Stock | 925,000 | $23.4M | 7.5% | −230,000−19.9% | Reduced | History |
| BDXBecton Dickinson & Co | Stock | 82,000 | $18.8M | 6.0% | +6,000+7.9% | Added | History |
| MDTMedtronic plc | Stock | 205,000 | $18.4M | 5.9% | −115,000−35.9% | Reduced | History |
| AMGNAmgen Inc | Stock | 59,000 | $18.4M | 5.9% | +13,000+28.3% | Added | History |
| JNJJohnson & Johnson | Stock | 98,000 | $16.3M | 5.2% | +20,000+25.6% | Added | History |
| GILDGilead Sciences, Inc. | Stock | 140,000 | $15.7M | 5.0% | −57,500−29.1% | Reduced | History |
| CVSCVS Health Corp | Stock | 202,000 | $13.7M | 4.4% | −15,000−6.9% | Reduced | History |
| ZBHZimmer Biomet Holdings, Inc. | Stock | 113,631 | $12.9M | 4.1% | −24,083−17.5% | Reduced | History |
| ELVElevance Health, Inc. | Stock | 28,779 | $12.5M | 4.0% | +11,500+66.6% | Added | History |
| CAHCardinal Health Inc | Stock | 88,000 | $12.1M | 3.9% | 00.0% | Unchanged | History |
| CNCCentene Corp | Stock | 177,000 | $10.7M | 3.4% | +7,000+4.1% | Added | History |
| BMRNBiomarin Pharmaceutical Inc | COM | 137,348 | $9.71M | 3.1% | −80,000−36.8% | Reduced | History |
| INCYIncyte Corp | COM | 159,000 | $9.63M | 3.1% | −38,400−19.5% | Reduced | History |
| EWEdwards Lifesciences Corp | Stock | 123,000 | $8.92M | 2.9% | +24,000+24.2% | Added | History |
| BRKRBruker Corp | COM | 211,970 | $8.85M | 2.8% | +53,000+33.3% | Added | History |
| IONSIonis Pharmaceuticals Inc | COM | 285,842 | $8.62M | 2.8% | +50,000+21.2% | Added | History |
| BAXBaxter International Inc | Stock | 247,650 | $8.48M | 2.7% | +89,000+56.1% | Added | History |
| QGENQiagen N.V. | COMMON STOCK | 187,000 | $7.51M | 2.4% | +187,000 | New | History |
| HUMHumana Inc | Stock | 25,000 | $6.62M | 2.1% | +11,000+78.6% | Added | History |
| THCTenet Healthcare Corp | COM NEW | 43,000 | $5.78M | 1.9% | +21,000+95.5% | Added | History |
| ELANElanco Animal Health Inc | COM | 477,073 | $5.01M | 1.6% | +200,166+72.3% | Added | History |
| GEHCGE HealthCare Technologies Inc. | Stock | 62,000 | $5.00M | 1.6% | +12,000+24.0% | Added | History |
| PTCTPTC Therapeutics, Inc. | COM | 92,250 | $4.70M | 1.5% | +27,000+41.4% | Added | History |
| TNDMTandem Diabetes Care Inc | COM NEW | 180,523 | $3.46M | 1.1% | +180,523 | New | History |
| BIOBio-Rad Laboratories, Inc. | CL A | 13,829 | $3.37M | 1.1% | −3,000−17.8% | Reduced | History |
| BNTXBioNTech SE | SPONSORED ADS | 30,000 | $2.73M | 0.9% | −10,000−25.0% | Reduced | History |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 17,000 | $2.65M | 0.8% | +17,000 | New | History |
| BIIBBiogen Inc. | COM | 18,639 | $2.55M | 0.8% | −10,361−35.7% | Reduced | History |
| LNTHLantheus Holdings, Inc. | Stock | 25,000 | $2.44M | 0.8% | −712−2.8% | Reduced | History |
| ACLXArcellx, Inc. | COMMON STOCK | 35,000 | $2.30M | 0.7% | +35,000 | New | History |
| SOLVSolventum Corp | Stock | 30,000 | $2.28M | 0.7% | +30,000 | New | History |
| TGTXTG Therapeutics, Inc. | COM | 55,000 | $2.17M | 0.7% | +55,000 | New | History |
Sold out since Q4 2024 (3)
Positions held at the end of Q4 2024 that are gone from this filing.